For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership in global COVID-19 vaccine distribution, along with robust supply chain efficiencies, Indian firms are strategically positioned to capitalize on this market shift. The departure of Chinese players from the market opens a significant gap, which Indian companies are well-equipped to fill .
HDFC Bank declares Rs 22 dividend for FY25, fixes June 27 as record date
HDFC Bank announced a dividend of Rs 22 per share for eligible shareholders, setting June 27, 2025, as the record date. The bank’s Q4 results